Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Coagulation Factor IX Antikörper

F9 Reaktivität: Human IHC (p), EIA, Neut Wirt: Schaf Polyclonal unconjugated
Produktnummer ABIN951596
  • Target Alle Coagulation Factor IX (F9) Antikörper anzeigen
    Coagulation Factor IX (F9)
    Reaktivität
    • 79
    • 28
    • 24
    • 5
    • 3
    • 1
    • 1
    Human
    Wirt
    • 61
    • 14
    • 10
    • 4
    • 3
    • 2
    • 1
    Schaf
    Klonalität
    • 79
    • 15
    Polyklonal
    Konjugat
    • 55
    • 12
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Coagulation Factor IX Antikörper ist unkonjugiert
    Applikation
    • 71
    • 41
    • 27
    • 13
    • 9
    • 9
    • 8
    • 7
    • 7
    • 6
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA), Neutralization (Neut)
    Spezifität
    Specific for FIX as analyzed by Immunoelectrophoresis and ELISA.
    Kreuzreaktivität (Details)
    Species reactivity (tested):Human.
    Aufreinigung
    Immunoaffinity Chromatography
    Immunogen
    Human Factor IX purified from plasma.
    Isotyp
    IgG
    Top Product
    Discover our top product F9 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1 mg/mL
    Buffer
    10 mM HEPES, pH 7.4, 0.15 M Sodium Chloride, 50 % Glycerol
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target
    Coagulation Factor IX (F9)
    Abstract
    F9 Produkte
    Synonyme
    AA407498 antikoerper, AI506714 antikoerper, AK-3 antikoerper, Ak3l antikoerper, Ak3l1 antikoerper, Akl3l antikoerper, FIX antikoerper, HEMB antikoerper, P19 antikoerper, PTC antikoerper, THPH8 antikoerper, AW111646 antikoerper, Cf-9 antikoerper, Cf9 antikoerper, f9 antikoerper, zgc:109775 antikoerper, fix antikoerper, ptc antikoerper, hemb antikoerper, FIXA antikoerper, zgc:136807 antikoerper, adenylate kinase 3 antikoerper, coagulation factor IX antikoerper, coagulation factor IXa antikoerper, coagulation factor 9 antikoerper, coagulation factor 9 S homeolog antikoerper, Coagulation factor IX antikoerper, coagulation factor IXb antikoerper, Ak3 antikoerper, F9 antikoerper, f9a antikoerper, f9 antikoerper, CpipJ_CPIJ003776 antikoerper, CpipJ_CPIJ009129 antikoerper, CpipJ_CPIJ013063 antikoerper, CpipJ_CPIJ013624 antikoerper, Tsp_01441 antikoerper, f9.S antikoerper, fa9 antikoerper, f9b antikoerper
    Hintergrund
    Coagulation Factor IX (F9) circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII. Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease.Synonyms: Christmas factor, PTC, Plasma thromboplastin component
    Gen-ID
    2158
    NCBI Accession
    NP_000124
Sie sind hier:
Kundenservice